Michael Barry
IrelandprofessorMale5.0Global Dominance: 0.00%Michael Barry is the Director of the National Centre for Pharmacoeconomics in Ireland, and he has been in the news for his comments regarding the reimbursement landscape for obesity drugs, including Wegovy.
Power4
Reach4,332
Country presence
Recent news mentions
Michael Barry is the clinical director of the National Centre for Pharmacoeconomics who explained the HSE's recommendation process.
Father of boy with Friedreich’s ataxia devastated as HSE recommends against drug funding – The Irish TimesThe Irish Times – major Irish daily, est. 1859·Ireland· 2026-08-12
Ireland· 2026-08-12
Michael Barry asked about marine worms seen at low tide on Dooneen Beach.
Is my house plant a menace to society? – The Irish TimesThe Irish Times – major Irish daily, est. 1859·Ireland· 2025-04-26
Ireland· 2025-04-26
Prof Michael Barry, who assesses medicines’ value for money, commented on the potential limitations of State coverage for weight loss drugs.
Weight loss drug Wegovy to cost around €220 a month as supplies go on market in Ireland – The Irish TimesThe Irish Times – major Irish daily, est. 1859·Ireland· 2025-03-25
Ireland· 2025-03-25Also mentioned
Camilla Sylvest
Prof Michael Barry assesses medicines’ value for money in his role as director of the National Centre for Pharmacoeconomics (NCPE).
The obesity ‘wonderdrug’ comes to Ireland, but it will cost you – The Irish TimesThe Irish Times – major Irish daily, est. 1859·Ireland· 2025-03-21
Ireland· 2025-03-21Also mentionedCamilla Sylvest